Blood–brain barrier P-glycoprotein function in Alzheimer's disease-Reference-Cited by-同舟云学术

Blood–brain barrier P-glycoprotein function in Alzheimer's disease

Published:2011-11-25 Issue:1 Volume:135 Page:181-189
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

van Assema Daniëlle M. E.,Lubberink Mark,Bauer Martin,van der Flier Wiesje M.,Schuit Robert C.,Windhorst Albert D.,Comans Emile F. I.,Hoetjes Nikie J.,Tolboom Nelleke,Langer Oliver,Müller Markus,Scheltens Philip,Lammertsma Adriaan A.,van Berckel Bart N. M.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/135/1/181/17863150/awr298.pdf

Reference69 articles.

1. Frequent amyloid deposition without significant cognitive impairment among the elderly;Aizenstein;Arch Neurol,2008

2. Biochemical, cellular, and pharmacological aspects of the multidrug transporter;Ambudkar;Annu Rev Pharmacol Toxicol,1999

3. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein;Bain;Toxicol Appl Pharmacol,1996

4. The blood–brain barrier and oncology: new insights into function and modulation;Bart;Cancer Treat Rev,2000

5. Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C]verapamil measured with PET;Bart;Neuroimage,2003

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer’s Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis;Brain, Behavior, and Immunity;2024-11

2. Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023;Frontiers in Pharmacology;2024-07-17

3. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17

4. Induction of P-glycoprotein overexpression in brain endothelial cells as a model to study blood-brain barrier efflux transport;Frontiers in Drug Delivery;2024-07-05

5. P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier;Gériatrie et Psychologie Neuropsychiatrie du Vieillissement;2024-06